Charanjeet S. Jassal

FDA investigator · also recorded as S. Charanjeet S. Jassal

Appears on 5 documents from 2015 to 2016, most often at sites in India. Most often cites production record review (21 CFR 211.192).

5
Documents on file
5.2
Observations per 483
2015
First seen
2016
Most recent

What they cite most

From 26 observations

Activity by year

2015: 3, 2016: 2

Where

India 2 · New York 2 · North Carolina 1

Is Charanjeet S. Jassal coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Lupin Limited (Unit II)Aug 12, 2016 · Madhya Pradesh, India
483 Fresenius Kabi USA, LLCFeb 4, 2016 · Grand Island, New York
483 Lupin LimitedJul 17, 2015 · Verna, India
483 Catalent Pharma Solutions LLCMar 20, 2015 · Morrisville, North Carolina
483 Time-Cap Laboratories, IncJan 16, 2015 · Farmingdale, New York

About this profile

What does Charanjeet S. Jassal inspect?

Charanjeet S. Jassal appears on 5 documents on file covering 5 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Charanjeet S. Jassal is dated Aug 12, 2016.